Immunogenicity and safety of a novel yeast Hansenula polymorpha-derived recombinant Hepatitis B candidate vaccine in healthy adolescents and adults aged 10-45 years (Q83065612)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 February 2010

Language	Label	Description	Also known as
English	Immunogenicity and safety of a novel yeast Hansenula polymorpha-derived recombinant Hepatitis B candidate vaccine in healthy adolescents and adults aged 10-45 years	scientific article published on 26 February 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189492%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Immunogenicity and safety of a novel yeast Hansenula polymorpha-derived recombinant Hepatitis B candidate vaccine in healthy adolescents and adults aged 10-45 years (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189492%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

based on heuristic

inferred from title

Hansenula polymorpha

object named as

Hansenula polymorpha

1 reference

based on heuristic

inferred from title

author name string

Miguel W Tregnaghi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189492%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Ricardo Voelker

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189492%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Eduardo Santos-Lima

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189492%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Betzana Zambrano

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189492%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

26 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189492%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189492%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189492%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189492%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

3595-3601

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189492%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.049

7 January 2021

Determinants for hepatitis B e antigen clearance in chronic type B hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.049

7 January 2021

Hepatitis B seroprevalence in Latin America

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.049

7 January 2021

Hepatitis B epidemiology in Latin America

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.049

7 January 2021

Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.049

7 January 2021

Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.049

7 January 2021

Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in neonates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.049

7 January 2021

A highly efficient integrated chromatographic procedure for the purification of recombinant hepatitis B surface antigen from Hansenula polymorpha.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.049

7 January 2021

Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): composition, structure and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.049

7 January 2021

Hepatitis B surface antigen (HBsAg) derived from yeast cells (Hansenula polymorpha) used to establish an influence of antigenic subtype (adw2, adr, ayw3) in measuring the immune response after vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.049

7 January 2021

A controlled clinical trial comparing the safety and immunogenicity of a new adjuvanted hepatitis B vaccine with a standard hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.049

7 January 2021

Comparison of thiomersal-free and thiomersal-containing formulations of a recombinant hepatitis B vaccine (Hepavax-Gene) in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.049

7 January 2021

Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.049

7 January 2021

Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.049

7 January 2021

Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.049

7 January 2021

Hepatitis B Vaccine Administered to Children and Adolescents at Yearly Intervals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.049

7 January 2021

Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.049

7 January 2021

Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.049

7 January 2021

Comparative study of the immunogenicity and safety of Engerix-B administered at 0, 1, 2 and 12 months and Recombivax HB administered at 0, 1, and 6 months in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.049

7 January 2021

Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.049

7 January 2021

Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.049

7 January 2021

Long-term persistence of anti-HBs after vaccination against HBV: an 18 year experience in health care workers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.049

7 January 2021

Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.049

7 January 2021

Major adverse reactions to yeast-derived hepatitis B vaccines--a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.049

7 January 2021

Identifiers

10.1016/J.VACCINE.2010.02.049

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189492%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20189492%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83065612&oldid=1802308428"